Lojer Oy

FDA Filings

This page includes the latest FDA filings for Lojer Oy. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3009307605
FEI Number3009307605
NameRobert Ballantine
Owner & OperatorLojer Oy
Contact AddressPutajantie 42
Sastamala FI-LS Lansi-Suomen laani FIN-38210 FI
US Agent
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration Address2220 Northmont Parkway
Duluth, GA 30096 US
Establishment TypeManufacture Medical Device



FDA Filings

Device
Company
DeviceDate
Lojer Oy
Manuthera 242 Manuthera 2422022-12-08
Lojer Oy
Capre FX5 Capre FX52022-12-08
Lojer Oy
Capre FX3 Capre FX32022-12-08
Lojer Oy
Capre F5 AM Capre F5 AM2022-12-08
Lojer Oy
Capre F5 Capre F52022-12-08
Lojer Oy
Capre F3 Capre F32022-12-08
Lojer Oy
Capre F2 Capre F22022-12-08
Lojer Oy
Capre M4 AM Capre M4 AM2022-12-08
Lojer Oy
Capre M4 Capre M42022-12-08
Lojer Oy
Capre M2 Capre M22022-12-08
Robert Ballantine [Lojer Oy]
Lojer Manuthera 2422017-01-16
Robert Ballantine [Lojer Oy]
Lojer Capre M Treatment Table2017-01-16
Robert Ballantine [Lojer Oy]
Lojer Capre FX Treatment Table2017-01-16
Robert Ballantine [Lojer Oy]
Lojer Capre F Treatment Table2017-01-16

Related Finance Registrations
NCAGE CodeA072GLOJER OY
CAGE CodeA072GLOJER OY
U.S. Import Records [external site]
Import IDShipmentCargo DescriptionQuantity
201904055247Anvers,Belgium -> Savannah, GeorgiaHOSPITAL EQUIPMENT, HS 940290 PHYSICAL EXCER .8 CAS
201902149155Anvers,Belgium -> New York/Newark Area, Newark, New JerseyCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019020913291Anvers,Belgium -> New York/Newark Area, Newark, New JerseyCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019020715688Anvers,Belgium -> New York/Newark Area, Newark, New JerseyCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019020613029Anvers,Belgium -> New York/Newark Area, Newark, New JerseyCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019020223522Anvers,Belgium -> New York/Newark Area, Newark, New JerseyCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019013135568Anvers,Belgium -> New York, New YorkCAPRE 5 SEXTION TREATMENT TABLE2 PKG
2019012636700Anvers,Belgium -> New York, New YorkCAPRE 5 SEXTION TREATMENT TABLE2 PKG

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.